Ventas (VTR) stock: key figures, P/E, revenue and dividend
Real Estate · Health Care REITs · United States · ISIN US92276F1003
Ventas financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 5.83 bn USD |
| EBIT | 859.61 m USD |
| Net income | 251.38 m USD |
| Diluted EPS – continuing operations | 0.54 USD |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ventas
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
More stocks
- Sun Life Financial Inc (SLF.TO)
- Ameriprise Financial (AMP)
- Banco Bradesco SA ADR (BBD)
- IQVIA (IQV)
- Danone SA (BN.PA)
- NetApp (NTAP)
- Haleon PLC (HLN.L)
- Ferguson Enterprises (FERG)
- Exelon (EXC)
- Holcim AG (HOLN.SW)
- Givaudan SA (GIVN.SW)
- Waters Corporation (WAT)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.